Maternal iAMP21 acute lymphoblastic leukemia detected on prenatal cell-free DNA genetic screening.

Luskin, Marlise R; Discenza, Marie N; Easter, Sarah Rae; Dal Cin, Paola; Owen, Renius; Ilagan, Bernard; Masiello, Meredith; Lane, Andrew A

Luskin, Marlise R; Discenza, Marie N; Easter, Sarah Rae; Dal Cin, Paola; Owen, Renius; Ilagan, Bernard; Masiello, Meredith; Lane, Andrew A.

Afiliação

Luskin MR; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.
Discenza MN; Harvard Medical School, Boston, MA.
Easter SR; Harvard Medical School, Boston, MA.
Dal Cin P; Center for Fetal Medicine and Prenatal Genetics.
Owen R; Harvard Medical School, Boston, MA.
Ilagan B; Division of Maternal-Fetal Medicine, and.
Masiello M; Harvard Medical School, Boston, MA.
Lane AA; Department of Pathology, Brigham and Women's Hospital, Boston MA; and.

Blood Adv ; 1(19): 1491-1494, 2017 Aug 22.

Article em En | MEDLINE | ID: mdl-29296790

RESUMO

cfDNA sequencing for fetal aneuploidy may detect chromosomal abnormalities representative of maternal malignancy.Maternal malignancy must be considered when abnormal cfDNA sequencing for fetal aneuploidy is associated with normal fetal karyotype.

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Screening_studies Idioma: En Revista: Blood Adv Ano de publicação: 2017 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google